Replacement of the Methylene of Dihydrochalcones with Oxygen: Synthesis and Biological Evaluation of 2-Phenoxyacetophenones

Chemical Biology and Drug Design

Volumn 80, Issue 4, 2012, Pages 591-597

  Ansari, Mahsa ^a   Emami, Saeed ^b   Khalilzadeh, Mohammad A ^c   Maghsoodlou, Malek T ^a   Foroumadi, Alireza ^d   Faramarzi, Mohammad A ^d   Samadi, Nasrin ^e   Ardestani, Sussan K ^f  

^a UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Acetophenone derivatives; Antifungal activity; Antileishmanial activity; Dihydrochalcones; Oximes; Promastigotes

Indexed keywords

2 (4 FLUOROPHENOXY) 1 PHENYLETHANONE OXIME; 2 PHENOXY 1 PHENYLETHANONE; ACETOPHENONE DERIVATIVE; CARBENE; CHALCONE DERIVATIVE; DIHYDROCHALCONE; FLUCONAZOLE; OXIME DERIVATIVE; OXYGEN; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BROTH DILUTION; CANDIDA ALBICANS; CANDIDA GLABRATA; DRUG SCREENING; IN VITRO STUDY; LEISHMANIA MAJOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SACCHAROMYCES CEREVISIAE;

ACETOPHENONES; ANTIFUNGAL AGENTS; CHALCONES; FUNGI; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICROBIAL SENSITIVITY TESTS; MYCOSES; OXYGEN; TRYPANOCIDAL AGENTS;

ASPERGILLUS NIGER; CANDIDA ALBICANS; CANDIDA GLABRATA; LEISHMANIA MAJOR; SACCHAROMYCES CEREVISIAE;

EID: 84866598698     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2012.01432.x     Document Type: Article

References (22)

1. Jung E.M., Lee Y.R. (2008) First concise total syntheses of biologically interesting nicolaioidesin C, crinatusinC1 and crinatusin C2. Bull Korean Chem Soc;29:1199-1204.
2. Szliszka E., Czuba Z.P., Mazur B., Paradysz A., Krol W. (2010) Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules;15:5336-5353.
3. Briot A., Baehr C., Brouillard R., Wagner A., Mioskows C. (2004) Concise synthesis of dihydrochalcones via palladium-catalyzed coupling of aryl halides and 1-aryl-2-propen-1-ols. J Org Chem;69:1374-1377.
4. Pan S., Mukherjee B., Ganguly A., Mitra S.R., Bhattacharya A. (1985) Antifungal activity of some naturally occurring flavonoids. Z Pflanzenkr Pflanzenschutz;92:392-395.
5. Okunade A.L., Hufford C.D., Clark A.L., Lentz D. (1997) Antimicrobial properties of the constituents of Piper aduncum. Phytother Res;11:142-144.
6. Mustafa K.A., Kjaergaard H.G., Perry N.B., Weavers R.T. (2003) Hydrogen-bonded rotamers of 2′, 4′, 6′-trihydroxy-3′-formyldihydrochalcone, an intermediate in the synthesis of a dihydrochalcone from Leptospermum recurvum. Tetrahedron;59:6113-6120.
7. Miles D.H., Rosa de Medeiros J.M., Chittawong V., Hedin P.A., Swithenbank C., Lidert Z. (1991) 3′-Formyl-2′, 4′, 6′-trihydroxydihydrochalcone from Psidium acutangulum. Phytochemistry;30:1131-1132.
8. Hermoso A., Jimenez I.A., Mamani Z.A., Bazzocchi I.L., Pinero J.E., Ravelo A.G., Valladares B. (2003) Antileishmanial activities of dihydrochalcones from Piper elongatum and synthetic related compounds. Structural requirements for activity. Bioorg Med Chem;11:3975-3980.
9. Narender T., Shweta, Gupta S. (2004) A convenient and biogenetic type synthesis of few naturally occurring chromenodihydrochalcones and their in vitro antileishmanial activity. Bioorg Med Chem Lett;14:3913-3916.
10. Kayser O., Kiderlen A.F., Folkens U., Kolodziej H. (1998) Antileishmanial activity of aurones. Planta Med;65:316-319.
11. Nielsen S.F., Kharazmi A., Christensen S.B. (1998) Modifications of the α, β-double bond in chalcones only marginally affect the antiprotozoal activities. Bioorg Med Chem;6:937-945.
12. Kayser O., Kiderlen A.F. (2001) In vitro leishmanicidal activity of naturally occurring chalcones. Phytother Res;15:148-152.
13. Emami S., Foroumadi A. (2007) Theoretical study on Z/E selectivity in the oximation of α-haloacetophenones. Asian J Chem;19:4727-4732.
14. National Committee for Clinical Laboratory Standards (2006) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard M27-A2. Wayne, PA, USA: National Committee for Clinical Laboratory Standards.
15. Dutta A., Bandyopadhyay S., Mandal C., Chatterjee M. (2005) Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis. Parasitol Int;54:119-122.
16. Emami S., Falahati M., Banifatemi A., Shafiee A. (2004) Stereoselective synthesis and antifungal activity of (Z)-trans-3-azolyl-2-methylchromanone oxime ethers. Bioorg Med Chem;12:5881-5889.
17. Emami S., Falahati M., Banifatemi A., Amanlou M., Shafiee A. (2004) (E)- and (Z)-1, 2, 4-Triazolylchromanone oxime ethers as conformationally constrained antifungals. Bioorg Med Chem;12:3971-3976.
18. Emami S., Shafiee A. (2001) Stereoselective syntheses of (E)- and (Z)-2, 3-dihydro-3-(1, 2, 4-triazolyl)-4H-1-benzopyran-4-one oxime ethers. Heterocycles;55:2059-2074.
19. Letafat B., Emami S., Mohammadhosseini N., Faramarzi M.A., Samadi N., Shafiee A., Foroumadi A. (2007) Synthesis and antibacterial activity of new N-(2-(thiophen-3-yl)ethyl) piperazinyl quinolones. Chem Pharm Bull;55:894-898.
20. Foroumadi A., Mohammadhosseini N., Emami S., Letafat B., Faramarzi M.A., Samadi N., Shafiee A. (2007) Synthesis and antibacterial activity of new 7-piperazinyl-quinolones containing a functionalized 2-(furan-3-yl)ethyl moiety. Arch Pharm;340:47-52.
21. Cerecetto H., González M. (2010) Synthetic medicinal chemistry in Chagas' disease: compounds at the final stage of "hit-to-lead" phase. Pharmaceuticals;3:810-838.
22. Lipinski C.A. (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol;1:337-341.